Issue 11, 2014

Adamantane amine derivatives as dual acting NMDA receptor and voltage-gated calcium channel inhibitors for neuroprotection

Abstract

The pathology of neurodegenerative disorders involves multiple pathways, and it is probably for this reason that targeting one particular step has only yielded limited results. The N-methyl-D-aspartate receptor (NMDAR) allows the influx of calcium ions for normal neuronal functioning. Overactivation of the NMDAR channel leads to excitotoxicity which can ultimately contribute to neuronal cell death. Calcium entry through voltage-gated calcium channels (VGCC) also contributes to this process. This paper describes a series of adamantane-derived compounds, structurally similar to NGP1-01, to act as dual channel inhibitors. By conjugating benzyl and phenylethyl moieties containing different functional groups (–H, –NO2, –NH2, –OCH3) to the structure of amantadine, we were able to synthesise compounds that display both VGCC and NMDAR channel inhibition. Compounds 1, 2, 5 and 10 displayed significant inhibitory activity against both NMDAR channel (66.7–89.5% at 100 μM) and VGCC (39.6–85.7% at 100 μM). The results obtained indicate that these compounds hold potential as neuroprotective drug candidates.

Graphical abstract: Adamantane amine derivatives as dual acting NMDA receptor and voltage-gated calcium channel inhibitors for neuroprotection

Article information

Article type
Concise Article
Submitted
10 6 2014
Accepted
18 8 2014
First published
22 8 2014

Med. Chem. Commun., 2014,5, 1678-1684

Adamantane amine derivatives as dual acting NMDA receptor and voltage-gated calcium channel inhibitors for neuroprotection

Y. E. Kadernani, F. T. Zindo, E. Kapp, S. F. Malan and J. Joubert, Med. Chem. Commun., 2014, 5, 1678 DOI: 10.1039/C4MD00244J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements